NCT04084340

Brief Summary

Urinary incontinence (UI) is defined as any involuntary loss of urine and can be divided into three types: urgency, stress and mixed. Pelvic floor exercises are considered the main non pharmacological choice for UI treatment. Its mechanisms are not fully understood, however there are some evidence that central mechanisms play an important role in the continence control. In this context, neuromodulatory techniques, such as transcranial direct current stimulation (tDCS), that address cortical targets has been demonstrated promising results in different health conditions. However, few studies have investigated the efficacy of adding tDCS to exercise therapies for women with UI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Nov 2019

Typical duration for phase_2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 10, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 14, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2023

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

1.2 years

First QC Date

September 2, 2019

Last Update Submit

November 27, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Urinary leakage

    Urinary leakage will be measured by the pad test. Pad testing yields an objective measurement of fluid loss over a certain period. The outcome of the 1-h pad test will be recorded as the weight gain as measured by a verified spring balance. Pad test assessment: Change in 1-hour exercise (stress), classified as mild, moderate or severe urinary leaking.

    4 weeks after randomization

  • Incontinence severity

    Incontinence severity will be assessed by the Brazilian version of Incontinence severity index (ISI) that quantifies the frequency and number of urinary leaking. The ISI comprehend two questions about quantity and frequency of urinary losses. The score are from 0 to 12: 0 continent 1 or 2 mild incontinence 3 or 6 moderate incontinence 8 or 9 severe incontinence 12 very severe incontinence

    4 weeks after randomization

  • Quality of life impact

    Quality of life impact of urinary incontinence will be assessed by the Brazilian Version of International consultation on incontinence questionnaire urinary incontinence (ICIQ\_UI short form). The ICIQ-UI Short form provides a score ranging from 0-21. With a higher score indicating greater severity of symptoms.

    4 weeks after randomization

Secondary Outcomes (9)

  • Urinary leakage

    3 and 6 months after randomization

  • Incontinence severity

    3 and 6 months after randomization ]

  • Quality of life impact

    3 and 6 months after randomization ]

  • Quality of life in women with UI (severity symptoms)

    4 weeks, 3 and 6 months after randomization

  • Emotional impact

    4 weeks, 3 and 6 months after randomization

  • +4 more secondary outcomes

Other Outcomes (3)

  • Depression

    4 weeks, 3 and 6 months after randomization

  • Anxiety

    4 weeks, 3 and 6 months after randomization

  • Satisfaction with care: Medrisk Instrument

    4 weeks after randomization

Study Arms (2)

Anodal tDCS + Exercises therapies

EXPERIMENTAL

Real transcranial direct current stimulation associated with therapeutic exercises tDCS: 20 minutes, 2mA

Procedure: Real transcranial direct current stimulation + therapeutic exercises for urinary incontinence

Sham tDCS + Exercises therapies

SHAM COMPARATOR

Sham transcranial direct current stimulation associated with therapeutic exercises tDCS: 20 minutes (30 seconds ON), 2mA

Procedure: Sham transcranial direct current stimulation + therapeutic exercises for urinary incontinence

Interventions

Real transcranial direct current stimulation associated with therapeutic exercises for urinary incontinence tDCS: 20 minutes, 2mA, motor supplementary area anode and supraorbital cathode (ipsilateral to the dominant lower limb).Technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively.

Anodal tDCS + Exercises therapies

Sham transcranial direct current stimulation + therapeutic exercises for urinary incontinence tDCS: 20 minutes (30 seconds ON), 2mA, motor supplementary area anode and supraorbital cathode (ipsilateral to the dominant lower limb).Technique based on the application of weak, direct electrical current to the brain through relatively large electrodes that are placed over the scalp, in which anodal and cathodal stimulation increases and decreases cortical excitability, respectively.

Sham tDCS + Exercises therapies

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Complaining of urinary loss
  • Seeking care for urinary incontinence

You may not qualify if:

  • Grade III vaginal dystopias
  • Intrapelvic tumors
  • Cardiac pacemaker or other implanted devices
  • Current pregnancy
  • Urinary tract infections
  • Previous treatment with tDCS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Physical Therapy. Federal University of Piaui

Parnaíba, Piauí, 64202-020, Brazil

Location

Antonia Mykaele Cordeiro Brandao

Parnaíba, Piauí, 642020020, Brazil

Location

MeSH Terms

Conditions

Urinary Incontinence

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor - Physical Therapy Department

Study Record Dates

First Submitted

September 2, 2019

First Posted

September 10, 2019

Study Start

November 14, 2019

Primary Completion

January 15, 2021

Study Completion

November 27, 2023

Last Updated

November 28, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations